Rights and permissions
About this article
Cite this article
Celecoxib, valdecoxib to gain from US FDA recommendations. Pharmacoecon. Outcomes News 475, 2 (2005). https://doi.org/10.2165/00151234-200504750-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504750-00002